These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29351735)

  • 21. Analysis of survival data with missing measurements of a time-dependent binary covariate.
    Halabi S; Wun CC; Davis BR
    J Biopharm Stat; 2003 May; 13(2):253-70. PubMed ID: 12729393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented inverse probability weighted estimator for Cox missing covariate regression.
    Wang CY; Chen HY
    Biometrics; 2001 Jun; 57(2):414-9. PubMed ID: 11414564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-sample tests for survival data from observational studies.
    Li C
    Lifetime Data Anal; 2018 Jul; 24(3):509-531. PubMed ID: 28849359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data.
    Du X; Li M; Zhu P; Wang J; Hou L; Li J; Meng H; Zhou M; Zhu C
    PLoS One; 2018; 13(8):e0200807. PubMed ID: 30133454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data.
    Zhang X; Zhang MJ; Fine J
    Stat Med; 2011 Jul; 30(16):1933-51. PubMed ID: 21557288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating bias correction in weighted proportional hazards regression.
    Pan Q; Schaubel DE
    Lifetime Data Anal; 2009 Mar; 15(1):120-46. PubMed ID: 18958616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-dependent covariates in the Cox proportional-hazards regression model.
    Fisher LD; Lin DY
    Annu Rev Public Health; 1999; 20():145-57. PubMed ID: 10352854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudo-observations for competing risks with covariate dependent censoring.
    Binder N; Gerds TA; Andersen PK
    Lifetime Data Anal; 2014 Apr; 20(2):303-15. PubMed ID: 23430270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cox regression with survival-time-dependent missing covariate values.
    Yi Y; Ye T; Yu M; Shao J
    Biometrics; 2020 Jun; 76(2):460-471. PubMed ID: 31549744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.
    Zhao Y; Saville BR; Zhou H; Koch GG
    J Biopharm Stat; 2016; 26(2):269-79. PubMed ID: 25635808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse probability weighting methods for Cox regression with right-truncated data.
    Vakulenko-Lagun B; Mandel M; Betensky RA
    Biometrics; 2020 Jun; 76(2):484-495. PubMed ID: 31621059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causal inference in survival analysis using pseudo-observations.
    Andersen PK; Syriopoulou E; Parner ET
    Stat Med; 2017 Jul; 36(17):2669-2681. PubMed ID: 28384840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improve efficiency and reduce bias of Cox regression models for two-stage randomization designs using auxiliary covariates.
    Yang X; Zhou Y
    Stat Med; 2017 May; 36(11):1683-1695. PubMed ID: 28183157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional transformation models for survivor function estimation.
    Möst L; Hothorn T
    Int J Biostat; 2015 May; 11(1):23-50. PubMed ID: 25719339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis.
    Fonseca I; Teixeira L; Malheiro J; Martins LS; Dias L; Castro Henriques A; Mendonça D
    Transpl Int; 2015 Jun; 28(6):738-50. PubMed ID: 25689397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study.
    Patson N; Mukaka M; Kazembe L; Eijkemans MJC; Mathanga D; Laufer MK; Chirwa T
    BMC Med Res Methodol; 2022 Jan; 22(1):24. PubMed ID: 35057743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network.
    Katzman JL; Shaham U; Cloninger A; Bates J; Jiang T; Kluger Y
    BMC Med Res Methodol; 2018 Feb; 18(1):24. PubMed ID: 29482517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bias due to aggregation of individual covariates in the Cox regression model.
    Abrahamowicz M; Du Berger R; Krewski D; Burnett R; Bartlett G; Tamblyn RM; Leffondré K
    Am J Epidemiol; 2004 Oct; 160(7):696-706. PubMed ID: 15383414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.
    Rosthøj S; Andersen PK; Abildstrom SZ
    Comput Methods Programs Biomed; 2004 Apr; 74(1):69-75. PubMed ID: 14992828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodal staging score: a tool for survival prediction of node-negative bladder cancer.
    Ku JH; Kim HH; Kwak C
    Urol Oncol; 2013 Nov; 31(8):1731-6. PubMed ID: 23141779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.